To provide some balance to the discussion:
Hadrian X is entering a key time and things may go wrong. Testing could result in technical issues that further delay or even, at worst, show the machine unworkable. Then there is always the risk that testing is OK but when it comes time to perform in front of the camera's, things go wrong. A lot of these risks are built in to the current price, IMO.
These scenarios are fairly apocalyptic for the company and by no means could be considered "highly unlikely". This is why, in my view, it is priced where it is at the moment. Once we are past these key stages, and if everything goes as planned (noting that most things never do), then that's where the massive value will come in.
The results are quite binary in that sense. Commercial agreement details, rollouts, units, manufacturer etc will just dictate how many multiples share price will go, IF the thing does what it is supposed to. If not... well it wouldn't be good at all.
The company are aware of this, and I think in part this is why we see the increase the news announcements and additional focus on development of new applications for the DST. If things do fall apart in this crunch time, there are prospects for survival, or at least some redeemable value for the DST.
Add to My Watchlist
What is My Watchlist?
